UAE’s ADQ to acquire Egypt’s Amoun Pharmaceutical Company

ADQ, one of the largest holding companies in the region, announced today (March 30) that it has entered into a definitive agreement to acquire Amoun Pharmaceutical Company SAE (Amoun), from Bausch Health Companies. 

 

Amoun is one of Egypt’s leading manufacturers, distributors and exporters of branded pharmaceutical and animal health products.

 

Amoun has a long-standing reputation for robust pharmaceuticals and life sciences products, addressing a wide range of acute and chronic conditions and highly prevalent diseases that demand treatment with proven high-quality medications.

 

The company’s flagship products include Hibiotic, Antinal, Alphintern, and Neuroton. Amoun has more than 2,500 employees and owns one of the largest, state-of-the-art pharma plants in Egypt.